IL6 and metabolic syndrome: Furthermore, there were significant differences between before and after subgroup analyses in the stratum of metabolic syndrome for TNF-α (SMD = − 1.42; 95% CI − 3.38, 0.55; p > 0.05) and the stratum of cardiovascular disease for IL-6 (SMD = − 0.42; 95% CI − 1.24, 0.39; p > 0.05).